Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary

被引：0
|
作者：
Esheba, G. E. [1 ]
Pate, L. L. [1 ]
Van De Rijn, M. [1 ]
Longacre, T. A. [1 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
893
引用
收藏
页码：196A / 196A
页数：1
相关论文
共 50 条
  • [21] Frequent Glypican-3 Overexpression in Ovarian Clear Cell Adenocarcinoma
    Maeda, D.
    Ota, S.
    Takazawa, Y.
    Aburatani, H.
    Nakagawa, S.
    Fukayama, M.
    LABORATORY INVESTIGATION, 2009, 89 : 226A - 226A
  • [22] Oncofetal Proteins IMP3, Glypican-3 and TPBG Expression in Urothelial Carcinoma of the Bladder
    Khani, F.
    Xylinas, E.
    Cha, E.
    Volkmer, B.
    Kluth, L.
    Scherr, D. S.
    Rubin, M. A.
    Mosquera, J. M.
    Hautmann, R. E.
    Kuefer, R.
    Shariat, S. F.
    Robinson, B. D.
    MODERN PATHOLOGY, 2013, 26 : 225A - 226A
  • [23] Frequent Glypican-3 Overexpression in Ovarian Clear Cell Adenocarcinoma
    Maeda, D.
    Ota, S.
    Takazawa, Y.
    Aburatani, H.
    Nakagawa, S.
    Fukayama, M.
    MODERN PATHOLOGY, 2009, 22 : 226A - 226A
  • [24] Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions
    Wang, H. L.
    Zhai, J.
    Adley, B.
    Anatelli, F.
    Chuang, S. T.
    King, X. J.
    MODERN PATHOLOGY, 2007, 20 : 295A - 295A
  • [25] Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions
    Wang, Hanlin L.
    Anatelli, Florencia
    Zhai, Qihui
    Adley, Brian
    Chuang, Shang-Tian
    Yang, Ximing J.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (11) : 1723 - 1728
  • [26] Advances in the study of oncofetal antigen glypican-3 expression in HBV-related hepatocellular carcinoma
    Yao, Min
    Wang, Li
    Fang, Miao
    Zheng, Wenjie
    Dong, Zhizhen
    Yao, Dengfu
    BIOSCIENCE TRENDS, 2016, 10 (05) : 337 - 343
  • [27] Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions
    Wang, H. L.
    Zhai, J.
    Adley, B.
    Anatelli, F.
    Chuang, S. T.
    Yang, X. J.
    LABORATORY INVESTIGATION, 2007, 87 : 295A - 295A
  • [28] Glypican-3 is a potential tumor marker for hepatocellular carcinoma.
    Kleeff, JH
    Zhu, ZW
    Wang, L
    Zimmermann, A
    Korc, M
    Friess, H
    Buchler, MW
    GASTROENTEROLOGY, 2000, 118 (04) : A261 - A261
  • [29] Oncofetal protein glypican-3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer
    Butler, William
    Xu, Lingfan
    Zhou, Yinglu
    Cheng, Qing
    Hauck, J. Spencer
    He, Yiping
    Marek, Robert
    Hartman, Zachary
    Cheng, Liang
    Yang, Qing
    Wang, Mu-En
    Chen, Ming
    Zhang, Hong
    Armstrong, Andrew J.
    Huang, Jiaoti
    JOURNAL OF PATHOLOGY, 2023, 260 (01): : 43 - 55
  • [30] Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma
    Suzuki, Shiro
    Yoshikawa, Toshiaki
    Hirosawa, Tomoya
    Shibata, Kiyosumi
    Kikkawa, Fumitaka
    Akatsuka, Yoshiki
    Nakatsura, Tetsuya
    CANCER SCIENCE, 2011, 102 (09) : 1622 - 1629
12345